# Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

> **NCT06731933** · PHASE2 · RECRUITING · sponsor: **Stanford University** · enrollment: 16 (estimated)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DRUG:** BVEC

## Key facts

- **NCT ID:** NCT06731933
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-28
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731933, "Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06731933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*